These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9513791)

  • 1. Physiological, biochemical and histological changes due to physostigmine in monkeys.
    Jeevaratnam K; Dasgupta S; Pravinkumar ; Pant SC; Sachan AS; Selvamurthy W; Ray US; Mukhopadhyay S; Purkayastha SS
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):25-38. PubMed ID: 9513791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physostigmine--an overview as pretreatment drug for organophosphate intoxication.
    Somani SM; Dube SN
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):367-87. PubMed ID: 2676871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physostigmine-induced hypothermic response in rats and its relationship with endogenous arginine vasopressin.
    Yang YL; Shen ZL; Zou Q; Tang Y; Huang T
    Life Sci; 2009 Oct; 85(15-16):586-91. PubMed ID: 19723529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradycardia produced by pyridostigmine and physostigmine.
    Stein RD; Backman SB; Collier B; Polosa C
    Can J Anaesth; 1997 Dec; 44(12):1286-92. PubMed ID: 9429048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for screening drug and chemical effects in laboratory rats using computerized quantitative electroencephalography.
    Jones RD; Sheets LP; Mueller RE
    Vet Hum Toxicol; 1996 Feb; 38(1):1-7. PubMed ID: 8825739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two scopolamine and physostigmine pretreatment regimens against nerve agent poisoning in the dog.
    Bonhage MR; Chilcoat CD; Li Q; Melendez V; Flournoy WS
    J Vet Pharmacol Ther; 2009 Apr; 32(2):146-53. PubMed ID: 19290944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method for screening drug and chemical effects in laboratory rats using computerized quantitative electroencephalography.
    Jones RD; Sheets LP; Mueller RE
    Vet Hum Toxicol; 1995 Dec; 37(6):521-7. PubMed ID: 8588286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cholinergic and noncholinergic mechanisms in the cardiorespiratory failure produced by N-methylcarbamate cholinesterase inhibitors in rabbits.
    Futagawa H; Kakinuma Y; Takahashi H
    Toxicol Appl Pharmacol; 2000 May; 165(1):27-36. PubMed ID: 10814550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular physostigmine enhances blood pressure and heat loss in running rats.
    Pires W; Wanner SP; La Guardia RB; Rodrigues LO; Silveira SA; Coimbra CC; Marubayashi U; Lima NR
    J Physiol Pharmacol; 2007 Mar; 58(1):3-17. PubMed ID: 17440222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression of the photic after discharge of flash evoked potentials by physostigmine, carbaryl and propoxur, and the relationship to inhibition of brain cholinesterase.
    Mwanza JC; Finley D; Spivey CL; Graff JE; Herr DW
    Neurotoxicology; 2008 Jan; 29(1):87-100. PubMed ID: 17950890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
    Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
    Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine antagonizes toxic action of anticholinesterase agents.
    Contreras CM; Marvan ML; Mexicano G; Puente A; Morfin A
    Bol Estud Med Biol; 1990; 38(1-2):10-5. PubMed ID: 2291776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in physiological and electrophysiological parameters in rabbits after single exposure to chlorphenvinphos.
    Gralewicz S; Tomas T; Górny R; Kowalczyk W; Soćko R
    Pol J Occup Med; 1989; 2(1):3-14. PubMed ID: 2489411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation.
    Kawabuchi M; Boyne AF; Deshpande SS; Cintra WM; Brossi A; Albuquerque EX
    Synapse; 1988; 2(2):139-47. PubMed ID: 3420535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cholinesterase inhibitors on a two-component chained schedule performance in rats.
    Liu WF
    Neurotoxicol Teratol; 2000; 22(3):389-96. PubMed ID: 10840182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
    Blick DW; Miller SA; Brown GC; Murphy MR
    Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential profiles of cholinesterase inhibition and neurobehavioral effects in rats exposed to fenamiphos or profenofos.
    McDaniel KL; Moser VC
    Neurotoxicol Teratol; 2004; 26(3):407-15. PubMed ID: 15113602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of physostigmine doses (0.1 mg, 0.3 mg, 0.6 mg) on the blood pressure, the body temperature and the heart rate in man.
    Hrbek J; Macáková J; Komenda S; Siroká A; Rypka M
    Acta Univ Palacki Olomuc Fac Med; 1985; 112():263-77. PubMed ID: 2938437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.